| Literature DB >> 24608969 |
Mulan Jiang1, Bing Guo2, Xia Wan3, Yangmin Gong4, Yinbo Zhang5, Chuanjiong Hu6.
Abstract
The diatom Phaeodactylum tricornutum can accumulate eicosapentaenoic acid (EPA) up to 30% of the total fatty acids. This species has been targeted for isolating gene encoding desaturases and elongases for long-chain polyunsaturated fatty acid (LC-PUFA) metabolic engineering. Here we first report the cloning and characterization of Δ5-elongase gene in P. tricornutum. A full-length cDNA sequence, designated PhtELO5, was shown to contain a 1110 bp open reading frame encoding a 369 amino acid polypeptide. The putative protein contains seven transmembrane regions and two elongase characteristic motifs of FLHXYHH and MYSYY, the latter being typical for microalgal Δ5-elongases. Phylogenetic analysis indicated that PhtELO5 belongs to the ELO5 group, tightly clustered with the counterpart of Thalassiosira pseudonana. Heterologous expression of PhtELO5 in Pichia pastoris confirmed that it encodes a specific Δ5-elongase capable of elongating arachidonic acid and eicosapentaenoic acid. Co-expression of PhtELO5 and IsFAD4 (a ∆4-desaturase from Isochrysis sphaerica) demonstrated that the high-efficiency biosynthetic pathway of docosahexaenoic acid was assembled in the transgenic yeast. Substrate competition revealed that PhtELO5 exhibited higher activity towards n-3 PUFA than n-6 PUFA. It is hypothesized that Phaeodactylum ELO5 may preferentially participate in biosynthesis of transgenic LC-PUFA via a n-3 pathway in the yeast host.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24608969 PMCID: PMC3967212 DOI: 10.3390/md12031317
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Microbial strains, plasmids and primers.
| Strain, Plasmid or Primer | Characteristic, Use and Source |
|---|---|
|
| |
| his4; Invitrogen (Invitrogen China Limited, Beijing, China) | |
| PHC01 | GS115 transformed by empty pHBM906 vector, as control |
| PHE5.01 | GS115 carrying pHBM-PtELO5, for gene expression |
| PHE5d.01 | GS115 carrying pHBM-PtELO5-Δ1, for gene expression |
| PHE5d.02 | GS115 carrying pHBM-PtELO5-Δ2, for gene expression |
| PAC01 | GS115 carrying pAO815, as control |
| PAE5.01 | GS115 carrying |
| PDE01 | GS115 carrying |
|
| |
| pMD18-T | T-cloning vector, Apr, Takara; for gene cloning |
| pHBM906 | Apr, transformation vector for |
| pHBM-ELO5 | Apr, PCR fragment containing |
| pAO815 | Apr, HIS4, |
| pAO-FAD4 | Apr, PCR fragment containing |
| pAO-ELO5 | Apr, PCR fragment containing |
| pT-ELO5 | Apr, PCR fragment containing |
| pAO-D4E5 | Apr, |
|
| |
| Ptelo5-U1 | 5′- GGGAGACCAGATGGTCGACG-3′ |
| Ptelo5-U2 | 5′- TCGCGATACCCCGAATATAT-3′ |
| Ptelo5-U3 | 5′- CAGTTGTCCCTTCAGAACAGC-3′ |
| Ptelo5-U4 | 5′- TCGTGTAGAAGAGCGTGGCG-3′ |
| Ptelo5-D1 | 5′- GCTCTGTAATATAGTGCTCTG-3′ |
| Ptelo5-U | 5′- |
| Ptelo5-D | 5′- |
| Ptelo5-del1F | 5′- |
| Ptelo5-del2F | 5′- |
| ISFAD4E-F | 5′- |
| ISFAD4E-R | 5′- |
| PTELO5E-F | 5′- |
| PTELO5E-R | 5′- |
| ELO5BGL-F | 5′- |
| ELO5BGL-R | 5′- |
| Co-F | 5′- GCTCATGATCAACGGGCTCTACCA-3′ |
| Co-R | 5′- TCCCCACACTGCGAAGACACCTAC-3′ |
| 5′AOX1 | 5′- GACTGGTTCCAATTGACAAGC-3′ |
| 3′AOX1 | 5′- GCAAATGGCATTCTGACATCC-3′ |
* Note: Primers Ptelo5-U1 to U4 and -D1 were used for PCR amplifications against putative PhtELO5 structural gene and cDNA; Ptelo5-U, -del1F, -del2F, and -D for PCR-cloning of the full length or truncated PhtELO5 into pHBM906; ISFAD4E-F and ISFAD4E-R for making vector pAO-IsFAD4; PTELO5E-F and PTELO5E-R for making pAO-PhtELO5; ELO5BGL-F and ELO5BGL-R for making ELO5 expression cassette and the subsequent gene stacking cascade; Co-F,Co-R,5′AOX1 and 3′AOX1 in combination with others for PCR and sequencing confirmation of constructs.
Figure 1Properties analysis of PhtELO5. (A) Prediction of seven transmembrane helices in PhtELO5 by online analysis of TMHMM program (Trans-Membrane prediction using Hidden Markov Models). The predicted regions of transmembrane helices are shown in red, other regions are predicted to be either inside (in blue) or outside (in pink) the membrane. (B) Multiple peptide sequence alignment (partly shown) was performed using the Clustal W and ESPript 3, highlighting the typical motifs of Δ5-elongase FLHXYHH and MYSYY which are underlined and boxed. Protein sequences used are the same as that in Figure 2.
Figure 2Phylogenetic dendrogram of fatty acid elongase families. The evolutionary relationship was inferred using the Neighbor-Joining method. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) are shown above the branches. Filled circles at nodes indicate phylogenetic branches that were also recovered by using maximum-parsimony algorithms. GenBank accession numbers of the sequences are ABR67690 (PavELO5; Pavlova viridis), AAV33630 (PasELO5; Pavlova sp. CCMP459), ACR53360 (PycELO5; Pyramimonas cordata), BAE71129 (MapELO5; Marchantia polymorpha), AAV67798 (OstELO5; Ostreococcus tauri), AAV67800 (ThpELO5; Thalassiosira pseudonana), AAT85662 (MapELO6; Marchantia polymorpha), AAW70157 (PtELO6; Phaeodactylum tricornutum), XP_003074750 (OstELO6; Ostreococcus tauri), AAV67799 (ThpELO6; Thalassiosira pseudonana), ACK99719 (PaiELO6; Parietochloris incisa), XP_001780388 (PhpELO6, Physcomitrella patens), AEA07666 (CooELO6; Conidiobolus obscurus), ACR53359 (PycELO6; Pyramimonas cordata), ADE06662 (MoaELO6; Mortierella alpina), ADN94475 (PapELO9; Pavlova pinguis), ADN94476 (ResELO9; Rebecca salina), AAL37626 (IsgELO9; Isochrysis galbana). TsELO1 (Thrasutcohytrium sp. ATCC26185, ref 22); PtELO5 (Phaeodactylum tricornutum, arrow shows this study).
Figure 3Comparison of fatty acid profiles of the control and PhtELO5-expressing Pichia cells. The representative control strain PHC01 (transformed with empty vector pHBM906) and representative ELO5-expressing strain PHE5.01 were grown for 3 days with or without adding substrate and subjected to FA analysis. Samples of 100 µM of (Δ5-) C20 PUFAs were exogenously fed as substrates. (A): control strain PHC01; (B): PhtELO5-expressing strain PHE5.01. Fatty acid profiles of immediate product from substrate were clearly observed in gene expressed cells but not in controls. Stars indicate substrates which were initially fed and detected as left-over in samples.
Figure 4Comparison of fatty acid profiles (partly shown) of the control and co-expressed Pichia cells fed with substrates. Control strain PAC01 (transformed with empty vector pAO815) and co-expressed strain PDE01 (transformed with pAO-D4E5) were fed with 100 µM of (Δ5-) C20 PUFAs and grown for 3 days, followed by FA analysis. Shown are fatty acid GC profiles of indicated strains fed with ARA (A), EPA (B) and ARA & EPA (C). Fatty acid profiles of immediate product from substrate were clearly observed in co-expressed cells but not in controls. Stars indicate substrates which were initially fed and detected as left-over in samples.
Fatty acid composition of transgenic P. pastoris GS115.
| Fatty Acid Composition
| ||||||||
|---|---|---|---|---|---|---|---|---|
| PAC01(E) | PDE01(E) | PAC01(A) | PDE01 (A) | PAC01(EA) | PDE01(EA) | PAC01(−) | PDE01(−) | |
| C14:0 | 9.75 ± 0.13 | 15.56 ± 0.23 | 9.77 ± 0.11 | 16.2 ± 0.09 | 10.12 ± 0.24 | 17.12 ± 0.23 | 8.98 ± 0.19 | 13.79 ± 0.24 |
| C16:0 | 3.01 ± 0.13 | 10.08 ± 0.32 | 2.98 ± 0.15 | 9.90 ± 0.14 | 3.11 ± 0.18 | 9.29 ± 0.27 | 3.48 ± 0.12 | 9.25 ± 0.21 |
| C17:0 | 1.01 ± 0.07 | 1.24 ± 0.04 | 1.23 ± 0.05 | 1.13 ± 0.15 | 1.31 ± 0.13 | 1.47 ± 0.09 | 1.36 ± 0.09 | 1.09 ± 0.04 |
| C17:1 | 2.90 ± 0.18 | 1.13 ± 0.15 | 3.01 ± 0.17 | 1.13 ± 0.15 | 3.32 ± 0.14 | 1.59 ± 0.11 | 2.50 ± 0.10 | 0.81 ± 0.08 |
| C18:0 | 6.89 ± 0.33 | 6.03 ± 0.39 | 7.24 ± 0.32 | 7.44 ± 0.22 | 7.54 ± 0.32 | 6.69 ± 0.23 | 6.80 ± 0.22 | 6.43 ± 0.10 |
| C18:1 | 2.87 ± 0.14 | 2.31 ± 0.18 | 2.79 ± 0.12 | 2.00 ± 0.11 | 3.07 ± 0.16 | 2.90 ± 0.19 | 2.24 ± 0.16 | 1.77 ± 0.07 |
| C18:1 | 42.86 ± 2.68 | 34.04 ± 2.01 | 39.13 ± 2.05 | 32.95 ± 2.92 | 38.55 ± 1.63 | 29.10 ± 1.92 | 38.14 ± 2.398 | 33.46 ± 1.73 |
| C18:2 | 19.09 ± 0.75 | 21.31 ± 0.67 | 18.67 ± 0.33 | 20.28 ± 0.64 | 17.27 ± 0.47 | 17.32 ± 0.69 | 28.63 ± 1.18 | 27.22 ± 0.73 |
| C18:3 | 4.62 ± 0.13 | 4.39 ± 0.19 | 4.68 ± 0.19 | 4.07 ± 0.13 | 4.16 ± 0.23 | 4.14 ± 0.16 | 6.14 ± 0.43 | 4.69 ± 0.08 |
| C20:0 | 1.79 ± 0.19 | 1.32 ± 0.23 | 1.26 ± 0.23 | 1.67 ± 0.12 | 1.74 ± 0.14 | 1.66 ± 0.11 | 1.72 ± 0.08 | 1.51 ± 0.05 |
| C20:4 | ND | ND | 7.82 ± 0.23 | 0.54 ± 0.04 | 3.32 ± 0.17 | 1.56 ± 0.05 | ND | ND |
| C20:5 | 5.27 ± 0.02 | 0.26 ± 0.02 | ND | ND | 5.31 ± 0.02 | 0.30 ± 0.02 | ND | ND |
| C22:4 | ND | ND | ND | 0.24 ± 0.01 | ND | 0.30 ± 0.02 | ND | ND |
| C22:5 | ND | ND | ND | 2.44 ± 0.03 | ND | 3.00 ± 0.07 | ND | ND |
| C22:5 | ND | 0.24 ± 0.03 | ND | ND | ND | 0.34 ± 0.01 | ND | ND |
| C22:6 | ND | 2.35 ± 0.05 | ND | ND | ND | 1.82 ± 0.03 | ND | ND |
Note: (1) Cells transformed with empty vector pAO815 (representative strain PAC01) or recombinant vector pAO-D4E5 (representative strain PDE01) grown on different substrate containing media were tested. (2) PAC01(E): Strain PAC01 with EPA; PDE01(E): Strain PDE01 with EPA; PAC01(A): Strain PAC01 with ARA; PDE01(A): Strain PDE01 with ARA; PAC01(EA): Strain PAC01with EPA and ARA; PDE01(EA): Strain PDE01 with EPA and ARA; PAC01(−): Strain PAC01 without adding substrate; PDE01(−): Strain PDE01 without adding substrate. ND: not detected or not detectable.
Substrate conversion rates by FAD4-ELO5 co-expressed transgenic yeast.
| Conversation Rate (%) | ||
|---|---|---|
| Addition of Single Substrate | Addition of Double Substrates | |
| EPA→DPA( | 90.8 | 87.9 |
| DPA( | 90.8 | 84.4 |
| ARA→DTA | 83.2 | 67.9 |
| DTA→DPA( | 90.9 | 90.9 |
Figure 5Fatty acid profiling patterns of transgenic Pichia cells expressing various versions of PhtELO5. Yeast cells transformed with empty vector pHBM906, and expression vectors containing ELO5-full length, ELO5-Δ1 and ELO5-Δ2 were fed with (Δ5-) C20 PUFAs and analyzed for FA composition. (A) to (D): indicated strains fed with EPA; (E) to (H): indicated strains fed with ARA.
Figure 6Schematic illustration of the heterologous assembly of microalgal ELO5 and FAD4 implementing EPA and DHA syntheses in transgenic yeast.